Madrigal Pharmaceuticals Inc (MDGL) Stock Price, Quote & News

Company Profile

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Industry: Biotechnology

Sector: Healthcare

Phone: 267 824 2827

Website: www.madrigalpharma.com

Address:

Four Tower Bridge, 200 Barr Harbor Drive Suite 200, West Conshohocken, United States

1986iamwallstreet Jul. 2 at 7:58 PM

$MDGL 🚀🚀🚀🚀

0 · Reply

1986iamwallstreet Jul. 2 at 7:58 PM

$MDGL long weekend 👀🚀🚀🚀🚀🚀

0 · Reply

Wallst45 Jul. 2 at 3:18 PM

$MDGL Buyout Weekend ?

2 · Reply

ReapN Jul. 2 at 12:47 PM

$SLS has ”Two” B.E.A.utiful Drugs ! $INSM for Lungs ! $IBRX soon to follow, Bladder ! $MDGL for MASH / NASH $LLY for extending Patented Rx & Shareholder Value Generationally

0 · Reply

AlertsAndNews Jul. 2 at 3:00 AM

$MDGL Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH "announce the successful achievement of the first candidate drug nomination milestone within their siRNA partnership. This milestone is the result of efficient collaboration and will be followed by immediate initiation of IND-enabling studies to support planned clinical studies."

0 · Reply

Wallst45 Jul. 1 at 6:54 PM

$MDGL what a low volume manipulation as usual lol 😂

1 · Reply

Layne_Thomas_Staley Jun. 30 at 10:45 PM

$GANX Look at $MDGL chart for what a successful first mover brought to market looks like for a previously untreated medical epidemic. I think Gain will be acquired, but in biotech, first mover advantage is everything. Ultimately, the science here is bulletproof and the need is dire.

2 · Reply